Arterial hypertension and chronic kidney disease - is everything under control?

Hypertension is one of the most common diseases that affects the heart and blood vessels. The number of people suffering from chronic kidney disease is increasing, but this disease often remains unrecognized until advanced stages. Kidney diseases can be the causes of arterial hypertension, but this connection is bidirectional and hypertension often leads to the development of chronic kidney disease. Of the non-pharmacological measures, dietary Na+ restriction is particularly effective, while pharmacological treatment of arterial hypertension in these patients should be started with renin–angiotensin system blockers. Second-line therapy may include either a long-acting dihydropyridine calcium channel blocker or diuretics, while third-line therapy is a combination of all three classes of drugs. The thiazide-like diuretic chlorthalidone is effective and can also be used in patients with advanced renal disease and uncontrolled hypertension, as well as in the treatment of resistant hypertension. Sodium-glucose cotransporter type 2 inhibitors and finerenone, although not registered as antihypertensive drugs, have this effect, and also improve renal and cardiovascular function, as well as outcomes of patients with albuminuria. Renal denervation is one of the treatment options for uncontrolled hypertension, but its effect on patients with advanced kidney disease has not yet been sufficiently studied.

Authors

Publication Details

Published
2025-01-01
DOI
https://doi.org/10.46793/karnef25.321a
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Arterial hypertension and chronic kidney disease - is everything under control?

Tijana Azaševac
Blood Pressure and Hypertension Studies
article

Arterial hypertension and chronic kidney disease - is everything under control?

Tijana Azaševac
article en

Abstract

Hypertension is one of the most common diseases that affects the heart and blood vessels. The number of people suffering from chronic kidney disease is increasing, but this disease often remains unrecognized until advanced stages. Kidney diseases can be the causes of arterial hypertension, but this connection is bidirectional and hypertension often leads to the development of chronic kidney disease. Of the non-pharmacological measures, dietary Na+ restriction is particularly effective, while pharmacological treatment of arterial hypertension in these patients should be started with renin–angiotensin system blockers. Second-line therapy may include either a long-acting dihydropyridine calcium channel blocker or diuretics, while third-line therapy is a combination of all three classes of drugs. The thiazide-like diuretic chlorthalidone is effective and can also be used in patients with advanced renal disease and uncontrolled hypertension, as well as in the treatment of resistant hypertension. Sodium-glucose cotransporter type 2 inhibitors and finerenone, although not registered as antihypertensive drugs, have this effect, and also improve renal and cardiovascular function, as well as outcomes of patients with albuminuria. Renal denervation is one of the treatment options for uncontrolled hypertension, but its effect on patients with advanced kidney disease has not yet been sufficiently studied.

Openalex Percentile: Top 78%
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Arterial hypertension and chronic kidney disease - is everything under control? — Tijana Azaševac · (2025) | TGRS Research Map | TGRS